Autoimmune cytopenia in chronic lymphocytic leukaemia: Diagnosis and treatment

British Journal of Haematology

Volumn 154, Issue 1, 2011, Pages 14-22

  Hodgson, Kate ^a   Ferrer, Gerardo ^a   Pereira, Arturo ^b   Moreno, Carol ^a,c   Montserrat, Emili ^a  

^a Institute of Hematology and Oncology   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Chronic lymphocytic leukaemia; Immune cytopenia; Immune disorders; Immune haemolytic anaemia; Immune thrombocytopenia

Indexed keywords

ALEMTUZUMAB; CHLORAMBUCIL; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ELTROMBOPAG; FLUDARABINE; FOLIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; PENTOSTATIN; PREDNISOLONE; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; ROMIPLOSTIM; VINCRISTINE;

AUTOIMMUNE CYTOPENIA; AUTOIMMUNE GRANULOCYTOPENIA; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BONE MARROW BIOPSY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COOMBS TEST; CYTOPENIA; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE THROMBOCYTOPENIA; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REVIEW; SPLENECTOMY; THROMBOCYTE TRANSFUSION;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 79958835948     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08707.x     Document Type: Review

References (83)

1. Ahn, Y.S. (2010) Triple play of H pylori in ITP. Blood, 115, 4155-4156.
2. Akpek, G., McAneny, D. & Weintraub, L. (1999) Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease. American Journal of Hematology, 61, 98-102.
3. Balduini, C.L., Cattaneo, M., Fabris, F., Gresele, P., Iolascon, A., Pulcinelli, F.M. & Savoia, A. (2003) Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica, 88, 582-592.
4. Barcellini, W., Montesano, R., Clerici, G., Zaninoni, A., Imperiali, F.G., Calori, R., Cortelezzi, A. & Zanella, A. (2002) In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. American Journal of Hematology, 71, 177-183.
5. Bastion, Y., Coiffier, B., Dumontet, C., Espinouse, D. & Bryon, P.A. (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Annals of Oncology, 3, 171-172.
6. Beardsley, D.S. & Ertem, M. (1998) Platelet autoantibodies in immune thrombocytopenic purpura. Transfusion Science, 19, 237-244.
7. Berchtold, P., Muller, D., Beardsley, D., Fujisawa, K., Kaplan, C., Kekomaki, R., Lipp, E., Morell-Kopp, M.C., Kiefel, V., McMillan, R., von dem Borne, A.E. & Imbach, P. (1997) International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies. British Journal of Haematology, 96, 477-483.
8. Borthakur, G., O'Brien, S., Wierda, W.G., Thomas, D.A., Cortes, J.E., Giles, F.J., Kantarjian, H.M., Lerner, S. & Keating, M.J. (2007) Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab - incidence and predictors. British Journal of Haematology, 136, 800-805.
9. Bowen, D.A., Call, T.G., Shanafelt, T.D., Kay, N.E., Schwager, S.M., Reinalda, M.S., Rabe, K.G., Slager, S.L. & Zent, C.S. (2010) Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone. Leukemia & Lymphoma, 51, 620-627.
10. British Committee for Standards in Haematology (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adutls, children and in pregnancy. British Journal of Haematology, 120, 574-596.
11. Bussel, J.B., Provan, D., Shamsi, T., Cheng, G., Psaila, B., Kovaleva, L., Salama, A., Jenkins, J.M., Roychowdhury, D., Mayer, B., Stone, N. & Arning, M. (2009) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet, 373, 641-648.
12. Byrd, J.C., Hertler, A.A., Weiss, R.B., Freiman, J., Kweder, S.L. & Diehl, L.F. (1995) Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Annals of Oncology, 6, 300-301.
13. Caligaris-Cappio, F. (1997) Relationship between autoimmunity and immunodeficiency in CLL. Hematology and Cell Therapy, 39, S13-S16.
14. Chemnitz, J., Draube, A., Diehl, V. & Wolf, J. (2002) Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab. American Journal of Hematology, 69, 232-233.
15. Chiorazzi, N., Rai, K.R. & Ferrarini, M. (2005) Chronic lymphocytic leukemia. New England Journal of Medicine, 352, 804-815.
16. Dameshek, W. (1967) Chronic lymphocytic leukemia - an accumulative disease of immunolgically incompetent lymphocytes. Blood, 29 (Suppl.), 566-584.
17. D'Arena, G. & Cascavilla, N. (2007) Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leukemia & Lymphoma, 48, 1072-1080.
18. D'Arena, G. & Cascavilla, N. (2011) Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia. Leukemia & Lymphoma, 52, 701-704.
19. D'Arena, G., Capalbo, S., Laurenti, L., Del Poeta, G., Nunziata, G., Deaglio, S., Spinosa, G., Tarnani, M., Di Padua, L., Califano, C., Ferrara, F. & Cascavilla, N. (2010) Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients. European Journal of Haematology, 85, 502-507.
20. Dearden, C. (2008) Disease-specific complications of chronic lymphocytic leukemia. Hematology, 450-456.
21. Dearden, C., Wade, R., Else, M., Richards, S., Milligan, D., Hamblin, T. & Catovsky, D. (2008) The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood, 111, 1820-1826.
22. Dungarwalla, M., Marsh, J.C.W., Tooze, J.A., Lucas, G., Ouwehand, W., Pettengell, R., Dearden, C.E., Gordon Smith, E.C. & Elebute, M.O. (2007) Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Annals of Hematology, 86, 191-197.
23. Dunleavy, K., Tay, K. & Wilson, W.H. (2010) Rituximab-associated neutropenia. Seminars in Hematology, 47, 180-186.
24. Evans, R.S., Takahashi, K., Duane, R.T., Payne, R. & Liu, C. (1951) Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. Archives of Internal Medicine, 87, 48-65.
25. Galton, D.A. (1966) The pathogenesis of chronic lymphocytic leukemia. Canadian Medical Association Journal, 94, 1005-1010.
26. Garratty, G. & Petz, L.D. (2007) Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy. British Journal of Haematology, 139, 622-623.
27. Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology, 141, 149-169.
28. Gentile, M., Lucia, E., Iorio, C., Vigna, E., Mazzone, C., Morelli, R., Bisconte, M.G., Gentile, C. & Morabito, F. (2008) Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient. Cancer Chemotherapy and Pharmacology, 62, 741-743.
29. George, J.N. (2010) Management of immune thrombocytopenia - something old, something new. New England Journal of Medicine, 363, 1959-1961.
30. Ghazal, H. (2002) Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood, 99, 1092-1094.
31. Ghia, P., Scielzo, C., Frenquelli, M., Muzio, M. & Caligaris-Cappio, F. (2007) From normal to clonal B cells: chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity. Autoimmunity Reviews, 7, 127-131.
32. Gribben, J.G. (2010) How I treat CLL up front. Blood, 115, 187-197.
33. Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. & Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111, 5446-5456.
34. Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A.M., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G., von Grunhagen, U., Bergmann, M., Catalano, J., Zinzani, P.L., Caligaris-Cappio, F., Seymour, J.F., Berrebi, A., Jager, U., Cazin, B., Trneny, M., Westermann, A., Wendtner, C.M., Eichhorst, B.F., Staib, P., Buhler, A., Winkler, D., Zenz, T., Bottcher, S., Ritgen, M., Mendila, M., Kneba, M., Dohner, H. & Stilgenbauer, S. (2010) Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet, 376, 1164-1174.
35. Hamblin, T.J., Oscier, D.G. & Young, B.J. (1986) Autoimmunity in chronic lymphocytic leukaemia. Journal of Clinical Pathology, 39, 713-716.
36. Hill, J., Walsh, R.M., McHam, S., Brody, F. & Kalaycio, M. (2004) Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature. American Journal of Hematology, 75, 134-138.
37. Hodgson, K., Ferrer, G., Montserrat, E. & Moreno, C. (2011) Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica, doi: [Epub ahead of print]
38. Karlsson, C., Hansson, L., Celsing, F. & Lundin, J. (2007) Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia, 21, 511-514.
39. Kaufman, M., Limaye, S.A., Driscoll, N., Johnson, C., Caramanica, A., Lebowicz, Y., Patel, D., Kohn, N. & Rai, K. (2009) A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia. Leukemia & Lymphoma, 50, 892-899.
40. Kipps, T.J. & Carson, D.A. (1993) Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood, 81, 2475-2487.
41. Koehrer, S., Keating, M.J. & Wierda, W.G. (2010) Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP. Leukemia, 24, 1096-1098.
42. Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovick, F.T., de Wolf, J.T., Bourgeois, E., Guthrie, Jr, T.H., Newland, A., Wasser, J.S., Hamburg, S.I., Grande, C., Lefrere, F., Lichtin, A.E., Tarantino, M.D., Terebelo, H.R., Viallard, J.F., Cuevas, F.J., Go, R.S., Henry, D.H., Redner, R.L., Rice, L., Schipperus, M.R., Guo, D.M. & Nichol, J.L. (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet, 371, 395-403.
43. Kuter, D.J., Mufti, G.J., Bain, B.J., Hasserjian, R.P., Davis, W. & Rutstein, M. (2009) Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood, 114, 3748-3756.
44. Kuter, D.J., Rummel, M., Boccia, R., Macik, B.G., Pabinger, I., Selleslag, D., Rodeghiero, F., Chong, B.H., Wang, X. & Berger, D.P. (2010) Romiplostim or standard of care in patients with immune thrombocytopenia. New England Journal of Medicine, 363, 1889-1899.
45. Kyasa, M.J., Parrish, R.S., Schichman, S.A. & Zent, C.S. (2003) Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Hematology, 74, 1-8.
46. Landgren, O., Engels, E.A., Caporaso, N.E., Gridley, G., Mellemkjaer, L., Hemminki, K., Linet, M.S. & Goldin, L.R. (2006) Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood, 108, 292-296.
47. Landgren, O., Gridley, G., Check, D., Caporaso, N.E. & Morris Brown, L. (2007) Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. British Journal of Haematology, 139, 791-798.
48. Laurenti, L., Tarnani, M., Efremov, D.G., Chiusolo, P., De Padua, L., Sica, S. & Leone, G. (2007) Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia. Leukemia, 21, 1819-1821.
49. Lechner, K. & Jager, U. (2010) How I treat autoimmune hemolytic anemias in adults. Blood, 116, 1831-1838.
50. Lewis, F.B., Schwartz, R.S. & Dameshek, W. (1966) X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease. Clinical and Experimental Immunology, 1, 3-11.
51. Marchand, A., Galen, R.S. & van Lente, F. (1980) The predictive value of serum haptoglobin in haemolytic disease. Journal of the American Medical Association, 243, 1909-1911.
52. Mauro, F.R., Foa, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F. & Girelli, G. (2000) Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood, 95, 2786-2792.
53. Mazzucconi, M.G., Fazi, P., Bernasconi, S., De Rossi, G., Leone, G., Gugliotta, L., Vianelli, N., Avvisati, G., Rodeghiero, F., Amendola, A., Baronci, C., Carbone, C., Quattrin, S., Fioritoni, G., D'Alfonso, G. & Mandelli, F. (2007) Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood, 109, 1401-1407.
54. Moreno, C., Hodgson, K., Ferrer, G., Elena, M., Filella, X., Pereira, A., Baumann, T. & Montserrat, E. (2010) Autoimmune cytopenias in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood, 116, 4771-4776.
55. Myint, H., Copplestone, J.A., Orchard, J., Craig, V., Curtis, D., Prentice, A.G., Hamon, M.D., Oscier, D.G. & Hamblin, T.J. (1995) Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 91, 341-344.
56. Narra, K., Borghaei, H., Al-Saleem, T., Höglund, M. & Smith, M.R. (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research, 30, 109-114.
57. Owen, J., de Gruchy, G.C. & Smith, H. (1960) Serum haptoglobins in haemolytic states. Journal of Clinical Pathology, 13, 478-482.
58. Pamuk, G.E., Turgut, B., Demir, M., Tezcan, F. & Vural, O. (2006) The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia. American Journal of Hematology, 81, 631-633.
59. Petz, L. (1996) Blood Transfusion in the acquired hemolytic anemias. In: Clinical practice of Transfusion Medicine (ed. by L. Petz, S.N. Swisher, S. Kleinman, R.K. Spence & R.G. Strauss), pp. 469-499. Churchill Livingstone, New York.
60. Poon, M.C. (2007) The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders. Transfusion Medicine Reviews, 21, 223-236.
61. Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168-186.
62. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
63. Riches, J.C., Ramsay, A.G. & Gribben, J.G. (2010) T-cell function in chronic lymphocytic leukaemia. Seminars in Cancer Biology, 20, 431-438.
64. Rossignol, J., Michallet, A.S., Oberic, L., Picard, M., Garon, A., Willekens, C., Dulery, R., Leleu, X., Cazin, B. & Ysebaert, L. (2011) Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia. Leukemia, 25, 473-478.
65. Royer, B., Vaida, I., Etienne, A., Garidi, R., Damaj, G. & Marolleau, J.P. (2007) Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab. Leukemia, 21, 1841-1842.
66. Sakurai, S., Shiojima, I., Tanigawa, T. & Nakahara, K. (1997) Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia. British Journal of Haematology, 99, 817-823.
67. Sinisalo, M., Sankelo, M. & Itälä-Remes, M. (2011) Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia. Leukemia and Lymphoma, 52, 724-725.
68. Söderberg, K.C., Jonsson, F., Winqvist, O., Hagmar, L. & Feychting, M. (2006) Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. European Journal of Cancer, 42, 3028-3033.
69. Swerdlow, S. & International Agency for Research on Cancer & World Health Organisation (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, France.
70. Tadmor, T. & Polliack, A. (2011) Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?. Leukemia and Lymphoma, 52, 558-559.
71. Tosti, S., Caruso, R., D'Adamo, F., Picardi, A., Ali Ege, M., Girelli, G., Mauro, F.R., Maurillo, L. & Amadori, S. (1992) Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Annals of Hematology, 65, 238-239.
72. Treleaven, J., Gennery, A., Marsh, J., Norfolk, D., Page, L., Parker, A., Saran, F., Thurston, J. & Webb, D. (2011) Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. British Journal of Haematology, 152, 35-51.
73. Viny, A.D., Lichtin, A., Pohlman, B., Loughran, T. & Maciejewski, J. (2008) Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leukemia & Lymphoma, 49, 932-938.
74. Visco, C., Giaretta, I., Ruggeri, M., Madeo, D., Tosetto, A. & Rodeghiero, F. (2007) Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia. Leukemia, 21, 1092-1093.
75. Visco, C., Ruggeri, M., Laura Evangelista, M., Stasi, R., Zanotti, R., Giaretta, I., Ambrosetti, A., Madeo, D., Pizzolo, G. & Rodeghiero, F. (2008) Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood, 111, 1110-1116.
76. Voog, E., Morschhauser, F. & Solal-Celigny, P. (2003) Neutropenia in patients treated with rituximab. New England Journal of Medicine, 348, 2691-2694.
77. Walker, R.H. (1990) American Association of Blood Banks Technical Manual. AABB, Arlington, VA.
78. Wolach, O., Bairey, O. & Lahav, M. (2010) Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine, 89, 308-318.
79. Zent, C.S. & Kay, N.E. (2010) Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL). Best Practice & Research Clinical Haematology, 23, 47-59.
80. Zent, C.S. & Shanafelt, T. (2009) Management of autoimmune cytopenia complicating chronic lymphocytic leukemia. Leukemia & Lymphoma, 50, 863-864.
81. Zent, C.S., Ding, W., Schwager, S.M., Reinalda, M.S., Hoyer, J.D., Jelinek, D.F., Tschumper, R.C., Bowen, D.A., Call, T.G., Shanafelt, T.D., Kay, N.E. & Slager, S.L. (2008) The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology, 141, 615-621.
82. Zent, C.S., Ding, W., Reinalda, M.S., Schwager, S.M., Hoyer, J.D., Bowen, D.A., Jelinek, D.F., Tschumper, R.C., Call, T.G., Shanafelt, T.D., Kay, N.E. & Slager, S.L. (2009) Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leukemia & Lymphoma, 50, 1261-1268.
83. Zenz, T., Mertens, D., Küppers, R., Döhner, H. & Stilgenbauer, S. (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nature Reviews. Cancer, 10, 37-50.